 effect daili etidron osteolysi multipl myeloma progress bone diseas multipl myeloma bone resorpt patholog fractur vertebr compress hypercalcemia double-blind studi multipl myeloma patient etidron disodium ehdp diphosphon compound bone resorpt osteoclast activ patient oral ehdp mg/kg/d placebo death discontinu due extent vertebr deform vertebr index height frequenc patholog fractur hypercalcemia bone pain size number osteolyt lesion patient melphalan prednison daili day week primari chemotherapi diseas repeat measur analysi signific height loss differ treatment arm signific differ bone pain episod hypercalcemia develop patholog fractur patient ehdp deterior vertebr index differ statist signific ehdp therapi dosag schedul signific impact multipl myeloma